Patents-Review.com
🔗 Permalink
Assignee profile:

Innate Pharma SA

City:

Marseille

Country:

France

Published Applications:

26

Last publication date:

2013-09-26

Patent Grants:

10

Last grant date:

2017-12-19

Top Inventors for applications by Innate Pharma SA

These are the the leading inventors for applications assigned to Innate Pharma SA:

Recent patent applications by Innate Pharma SA

Innate Pharma SA based in Marseille, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-09-26 ✅ Patent 9,844,593 granted on 2017-12-19
US20130251711A1
Human necessities

Methods for treatment of recurrent hematological malignancies

 #2 | 2012-12-27 ✅ Patent 9,067,997 granted on 2015-06-30
US20120328615A1
Chemistry; metallurgy

Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders

 #3 | 2011-09-22
US20110229486A1
Human necessities

Monoclonal Antibodies Against NKG2A

 #4 | 2011-07-28
US20110185441A1
Chemistry; metallurgy

TRANSGENIC ANIMALS AND METHODS OF MAKING RECOMBINANT ANTIBODIES

 #5 | 2011-03-31
US20110076296A1
Chemistry; metallurgy

TLR3 Agonist Compositions

 #6 | 2010-11-18 ✅ Patent 8,637,258 granted on 2014-01-28
US20100291110A1
Chemistry; metallurgy

Compositions and methods for regulating NK cell activity

 #7 | 2010-11-11 ✅ Patent 8,465,931 granted on 2013-06-18
US20100285531A1
Human necessities

Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor

 #8 | 2010-10-07
US20100254940A1
Human necessities

Compositions and Methods for Regulating an Immune Response in a Subject

 #9 | 2010-09-02
US20100222306A1
Chemistry; metallurgy

Class of Gamma Delta T Cells Activators and Use Thereof

 #10 | 2010-07-29
US20100189681A1
Human necessities

Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of Cancer

 #11 | 2010-05-20
US20100124555A1
Chemistry; metallurgy

Compositions and Methods for Treating Pancreatic Tumors

 #12 | 2010-02-04
US20100029674A1
Human necessities

Methods of Using Phosphoantigen for the Treatment of Cancer

 #13 | 2010-01-21
US20100015153A1
Chemistry; metallurgy

Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same

 #14 | 2009-12-10
US20090304688A1
Human necessities

Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell Activators

 #15 | 2009-08-20 ✅ Patent 8,993,319 granted on 2015-03-31
US20090208416A1
Human necessities

Monoclonal antibodies against NKG2A

 #16 | 2008-10-09
US20080248045A1
Chemistry; metallurgy

POLYPEPTIDES HAVING A TRIGGERING NK ACTIVITY AND BIOLOGICAL APPLICATIONS

 #17 | 2008-08-28 ✅ Patent 7,683,045 granted on 2010-03-23
US20080207568A1
Chemistry; metallurgy

Class of γδ T cells activators and use thereof

 #18 | 2008-08-14
US20080196112A1
Chemistry; metallurgy

Transgenic Animals and Methods of Making Recombinant Antibodies

 #19 | 2008-08-14
US20080196111A1
Chemistry; metallurgy

Expression Vectors and Methods for Obtaining Nk Cell Specific Expression

 #20 | 2008-04-03 ✅ Patent 7,732,131 granted on 2010-06-08
US20080081346A1
Human necessities

Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor

 #21 | 2007-10-25 ✅ Patent 7,767,842 granted on 2010-08-03
US20070249565A1
Chemistry; metallurgy

Class of γδ T cells activators and use thereof

 #22 | 2007-10-04
US20070231322A1
Chemistry; metallurgy

Compositions and Methods for Treating Proliferative Disorders Such as Nk-Type Ldgl

 #23 | 2007-09-20
US20070218086A1
Human necessities

Adjuvant Composition and Methods for Its Use

 #24 | 2007-03-22
US20070065875A1
Chemistry; metallurgy

NTB-A, a surface molecule involved in natural killer cells activity

 #25 | 2006-11-23 ✅ Patent 9,902,936 granted on 2018-02-27
US20060263361A1
Human necessities

PAN-KIR2DL NK-receptor antibodies and their use in diagnostics and therapy

 #26 | 2006-11-02 ✅ Patent 7,279,291 granted on 2007-10-09
US20060246068A1
Chemistry; metallurgy

Polypeptides having a triggering NK activity and biological applications
AssigneeID:

195912 ⎘